Semax + Selank Blend – Research-Grade Synthetic Neuropeptide Combination

The Semax + Selank blend is a synthetic combination of two well-characterized neuropeptides originally developed as analogs of endogenous regulatory peptides. Semax is derived from adrenocorticotropic hormone (ACTH) fragments, while Selank is a modified analog of the immunomodulatory peptide tuftsin. When combined, these peptides provide a defined molecular system for studying peptide–receptor interactions, signal transduction pathways, and structure–function relationships within neurochemical and neuroimmune research models.

In laboratory research environments, the Semax + Selank blend is utilized to examine peptide stability, receptor binding affinity, and intracellular signaling dynamics associated with synthetic neuropeptide analogs. The absence of full-length endogenous protein structures allows researchers to isolate specific molecular motifs and evaluate their biochemical behavior under controlled experimental conditions. This blend is commonly employed in mechanistic studies, comparative peptide analyses, and exploratory research involving neuropeptide signaling frameworks.